Epigenetic silencing of TPM2 contributes to colorectal cancer progression upon RhoA activation

@article{Cui2016EpigeneticSO,
  title={Epigenetic silencing of TPM2 contributes to colorectal cancer progression upon RhoA activation},
  author={Ji Cui and Y. Cai and Ying Hu and Zenghong Huang and Yanxin Luo and Andrew M. Kaz and Zihuan Yang and Dianke Chen and Xinjuan Fan and William M. Grady and Jianping Wang},
  journal={Tumor Biology},
  year={2016},
  volume={37},
  pages={12477-12483}
}
Beta-tropomyosin (β-tropomyosin, TPM2) has been found to be downregulated in colorectal cancer (CRC) in previous studies. In this study, we aimed to investigate the mechanisms and potential biological consequences of the downregulation of TPM2 in colorectal cancer. TPM2 expression in colorectal cancer was assessed by qRT-PCR and immunostaining. The biological functions of TPM2 were assessed in cell lines either overexpressing or underexpressingTPM2. Aberrant DNA methylation in the promoter… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-2 of 2 extracted citations

A Possible Role for Long Interspersed Nuclear Elements-1 (LINE-1) in Huntington’s Disease Progression

Medical science monitor : international medical journal of experimental and clinical research • 2018
View 10 Excerpts
Highly Influenced

Hypoxia-Induced TPM2 Methylation is Associated with Chemoresistance and Poor Prognosis in Breast Cancer.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology • 2018

References

Publications referenced by this paper.
Showing 1-10 of 20 references

Cancer statistics ,

WM Grady, JM Carethers
2013

Cancer statistics, 2013.

CA: a cancer journal for clinicians • 2013

Myopathies associatedwith beta - tropomyosin mutations

L Wang
Neuromuscul Disord . • 2012

Similar Papers

Loading similar papers…